首页> 中文期刊> 《癌症中的人工智能(英文)》 >Application of artificial intelligence in clinical non-small cell lung cancer

Application of artificial intelligence in clinical non-small cell lung cancer

         

摘要

Lung cancer is the most common cause of cancer death in the world.Early diagnosis,screening and precise individualized treatment can significantly reduce the death rate of lung cancer.Artificial intelligence(AI)has been shown to be able to help clinicians make more accurate judgments and decisions in many ways.It has been involved in the screening of lung cancer,the judgment of benign and malignant degree of pulmonary nodules,the classification of histological cancer,the differentiation of histological subtypes,the identification of genomics,the judgment of the effectiveness of treatment and even the prognosis.AI has shown that it can be an excellent assistant for clinicians.This paper reviews the application of AI in the field of non-small cell lung cancer and describes the relevant progress.Although most of the studies to evaluate the clinical application of AI in non-small cell lung cancer have not been repeatable and generalizable,the research results highlight the efforts to promote the clinical application of AI technology and influence the future treatment direction.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号